Cargando…
Almotriptan in the treatment of migraine
Almotriptan is an orally administered, highly selective serotonin 5-HT(1(B)/1(D)) receptor agonist that is effective in the acute treatment of moderate to severe migraine attacks. Since its introduction on to the market in 2001, several studies involving a large number of migraine patients have conf...
Autores principales: | Sandrini, Giorgio, Perrotta, Armando, Arce Leal, Natalia L, Buscone, Simona, Nappi, Giuseppe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656322/ https://www.ncbi.nlm.nih.gov/pubmed/19300615 |
Ejemplares similares
-
Rizatriptan in the treatment of migraine
por: Láinez, Miguel JA
Publicado: (2006) -
Review of frovatriptan in the treatment of migraine
por: Kelman, Leslie
Publicado: (2008) -
Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
por: Naegel, Steffen, et al.
Publicado: (2010) -
Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability
por: D’Amico, Domenico, et al.
Publicado: (2006) -
Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan
por: Allais, Gianni, et al.
Publicado: (2010)